Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (101-110 of 511) with videos related to

Pageof 52
Sort By:
JHEP Reports : Innovation in Hepatology|September 10, 2021
Reply to: "The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites"Michael Praktiknjo, Antonia Witt, Filippo Schepis, et al.
Frontiers in Oncology|December 17, 2021
The Role of Decorin and Biglycan Signaling in TumorigenesisValentina Diehl, Lisa Sophie Huber, Jonel Trebicka, et al.
International Journal of Molecular Sciences|September 13, 2025
IL-24 in COVID-19 Patients: Correlations with Disease ProgressionRichard Vollenberg, Katharina Schütte-Nütgen, Markus Strauss, et al.
Seminars in Cancer Biology|August 15, 2019
Danger matrix molecules orchestrate CD14/CD44 signaling in cancer developmentHeiko Roedig, Roxana Damiescu, Jinyang Zeng-Brouwers, et al.
Zeitschrift Fur Gastroenterologie|November 11, 2022
Frank Tacke, Markus Cornberg, Martina Sterneck, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 17, 2004
Agmatine (decarboxylated arginine), a modulator of liver cell homeostasis and proliferationBettina Kribben, Jörg Heller, Jonel Trebicka, et al.
United European Gastroenterology Journal|June 19, 2019
Establishing an indwelling peritoneal catheter as a standard procedure for hospitalized patients with ascites: Retrospective data on feasibility, effectiveness and safetyKatharina Stratmann, Daniel Fitting, Stefan Zeuzem, et al.
Zeitschrift Fur Gastroenterologie|June 7, 2019
[Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany]Thomas Horvatits, Andreas Drolz, Malte Wehmeyer, et al.
Deutsches Arzteblatt International|January 8, 2025
Acute on Chronic Liver FailureJonel Trebicka, Michael Praktiknjo, Kai-Henrik Peiffer, et al.
Trials|February 28, 2018
Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trialBjørn Stæhr Madsen, Jonel Trebicka, Maja Thiele, et al.
Pageof 52

Showing results (101-110 of 511) with videos related to

Sort By:
Pageof 52
JHEP Reports : Innovation in Hepatology|September 10, 2021
Reply to: "The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites"Michael Praktiknjo, Antonia Witt, Filippo Schepis, et al.
Frontiers in Oncology|December 17, 2021
The Role of Decorin and Biglycan Signaling in TumorigenesisValentina Diehl, Lisa Sophie Huber, Jonel Trebicka, et al.
International Journal of Molecular Sciences|September 13, 2025
IL-24 in COVID-19 Patients: Correlations with Disease ProgressionRichard Vollenberg, Katharina Schütte-Nütgen, Markus Strauss, et al.
Seminars in Cancer Biology|August 15, 2019
Danger matrix molecules orchestrate CD14/CD44 signaling in cancer developmentHeiko Roedig, Roxana Damiescu, Jinyang Zeng-Brouwers, et al.
Zeitschrift Fur Gastroenterologie|November 11, 2022
Frank Tacke, Markus Cornberg, Martina Sterneck, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 17, 2004
Agmatine (decarboxylated arginine), a modulator of liver cell homeostasis and proliferationBettina Kribben, Jörg Heller, Jonel Trebicka, et al.
United European Gastroenterology Journal|June 19, 2019
Establishing an indwelling peritoneal catheter as a standard procedure for hospitalized patients with ascites: Retrospective data on feasibility, effectiveness and safetyKatharina Stratmann, Daniel Fitting, Stefan Zeuzem, et al.
Zeitschrift Fur Gastroenterologie|June 7, 2019
[Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany]Thomas Horvatits, Andreas Drolz, Malte Wehmeyer, et al.
Deutsches Arzteblatt International|January 8, 2025
Acute on Chronic Liver FailureJonel Trebicka, Michael Praktiknjo, Kai-Henrik Peiffer, et al.
Trials|February 28, 2018
Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trialBjørn Stæhr Madsen, Jonel Trebicka, Maja Thiele, et al.
Pageof 52